Optimize Your Ocular In-Vitro Models with Clinically Ready Media & 3D Systems. 

Millions of people worldwide are affected by vision loss caused by corneal disorders, age-related macular degeneration (AMD), retinitis pigmentosa, and other ocular diseases. As the need for regenerative therapies and physiologically relevant in vitro disease models grows, CELLnTEC is committed to empowering researchers with advanced media and tools optimized for  the culture of human corneal epithelial cells, corneal melanocytes, limbal cells, and other ocular cell types. 

Our precision culture systems provide chemically defined, serum-free, and animal component-free conditions that ensure consistent, high-quality cell populations suitable for downstream applications. Whether isolating primary corneal epithelial cells or differentiating iPSC-derived retinal or limbal progenitors, our platforms support robust workflows tailored for both 2D and 3D assay formats. These systems enable the creation of tissue-like models that more accurately mimic in vivo physiology, accelerating discoveries that may one day help restore vision.

From disease modeling to drug screening to regenerative therapy development, CELLnTEC’s ocular culture solutions are designed to deliver scientific rigor, reproducibility, scalability, and translational readiness to bring your research one step closer to real-world clinical impact. Visit our Ophthalmology webpage and discover how you can enhance your ocular research.

As the year takes shape, we would like to thank you for your continued trust and collaboration. The CELLnTEC team wishes you a healthy, successful, and inspiring year ahead.